Prelude Capital Management’s Abbott ABT Stock Holding History

Prelude Capital Management’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,000	Closed	-$837K	–	1870
2019 Q3	$837K	Buy	+10,000	New	+$850K	0.04%	381

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prelude Capital Management's ABT Position: Q2 2025 in Review

Prelude Capital Management sold out of Abbott (ABT) in Q2 2025, closing a stake of 6,785 shares — an estimated $900K sold.

Prelude Capital Management first reported a position in ABT in Q1 2014 and held it in 28 quarters. The position peaked at $2.87M in Q2 2022. 3,184 funds tracked by Wall St. Rank hold ABT as of Q2 2025.

Prelude Capital Management reported no remaining Abbott position as of Q2 2025 after selling out during the quarter.
Prelude Capital Management sold 6,785 Abbott shares in Q2 2025, an estimated $900K.
Prelude Capital Management first reported a position in Abbott in Q1 2014 and held it in 28 quarters.
Prelude Capital Management's Abbott position peaked at $2.87M in Q2 2022.
3,184 funds tracked by Wall St. Rank held Abbott as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.